Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor

Amer Assal, Baoxia Dong, Hina Khan, Ramadevi Medavarapu, Aditi Shastri, Kith Pradhan, Ellen Friedman, Ioannis Mantzaris, Murali Janakiram, Ramakrishna Battini, Noah Kornblum, Yiting Yu, Amit Verma, Ira Braunschweig, Olga Derman

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor'. Together they form a unique fingerprint.